Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1966 1
1967 1
1973 1
1974 1
1976 3
1977 2
1979 1
1982 1
1984 1
1987 1
1989 1
1993 1
1994 1
1995 1
1996 2
1997 1
1999 1
2000 1
2001 3
2003 2
2006 2
2011 1
2012 1
2014 1
2020 1
2021 1
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.
Powles T, Park SH, Voog E, Caserta C, Valderrama BP, Gurney H, Kalofonos H, Radulović S, Demey W, Ullén A, Loriot Y, Sridhar SS, Tsuchiya N, Kopyltsov E, Sternberg CN, Bellmunt J, Aragon-Ching JB, Petrylak DP, Laliberte R, Wang J, Huang B, Davis C, Fowst C, Costa N, Blake-Haskins JA, di Pietro A, Grivas P. Powles T, et al. Among authors: laliberte r. N Engl J Med. 2020 Sep 24;383(13):1218-1230. doi: 10.1056/NEJMoa2002788. Epub 2020 Sep 18. N Engl J Med. 2020. PMID: 32945632 Clinical Trial.
Bumps in the journey toward a new care delivery model.
Shendell-Falik N, Ide P, Mohr BJ, Laliberte RA, de Guerre DW. Shendell-Falik N, et al. Among authors: laliberte ra. Nurs Adm Q. 2012 Jul-Sep;36(3):243-52. doi: 10.1097/NAQ.0b013e318258c4f4. Nurs Adm Q. 2012. PMID: 22677965
Feasibility and Initial Safety Evaluation of Inhaled 13C-Urea in Ambulatory Patients with Pneumonia.
Baca JT, Parchim NF, Kotulski J, Femling J, Taylor RM, Bussmann S, Candelaria L, Norii T, Moyer M, Laliberte R, Patel S, Odeesho S, Nowak R. Baca JT, et al. Among authors: laliberte r. J Aerosol Med Pulm Drug Deliv. 2022 Jan;35(1):57-59. doi: 10.1089/jamp.2021.0050. Epub 2021 Nov 5. J Aerosol Med Pulm Drug Deliv. 2022. PMID: 34748404 Free PMC article. No abstract available.
Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer.
Powles T, Park SH, Voog E, Caserta C, Valderrama BP, Gurney H, Kalofonos H, Radulovic S, Demey W, Ullén A, Loriot Y, Sridhar SS, Tsuchiya N, Kopyltsov E, Sternberg CN, Bellmunt J, Aragon-Ching JB, Petrylak DP, Laliberte RJ, Huang B, Costa N, Blake-Haskins JA, Grivas P. Powles T, et al. Among authors: laliberte rj. Future Oncol. 2022 Jun;18(19):2361-2371. doi: 10.2217/fon-2021-1631. Epub 2022 Apr 13. Future Oncol. 2022. PMID: 35416053 Free article. Review.
Structure-activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical development.
McClure KF, Letavic MA, Kalgutkar AS, Gabel CA, Audoly L, Barberia JT, Braganza JF, Carter D, Carty TJ, Cortina SR, Dombroski MA, Donahue KM, Elliott NC, Gibbons CP, Jordan CK, Kuperman AV, Labasi JM, Laliberte RE, McCoy JM, Naiman BM, Nelson KL, Nguyen HT, Peese KM, Sweeney FJ, Taylor TJ, Trebino CE, Abramov YA, Laird ER, Volberg WA, Zhou J, Bach J, Lombardo F. McClure KF, et al. Among authors: laliberte re. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4339-44. doi: 10.1016/j.bmcl.2006.05.056. Epub 2006 Jun 12. Bioorg Med Chem Lett. 2006. PMID: 16759861
The role for interleukin-12 therapy of cutaneous T cell lymphoma.
Rook AH, Zaki MH, Wysocka M, Wood GS, Duvic M, Showe LC, Foss F, Shapiro M, Kuzel TM, Olsen EA, Vonderheid EC, Laliberte R, Sherman ML. Rook AH, et al. Among authors: laliberte r. Ann N Y Acad Sci. 2001 Sep;941:177-84. doi: 10.1111/j.1749-6632.2001.tb03721.x. Ann N Y Acad Sci. 2001. PMID: 11594571 Clinical Trial.
Phase I first-in-human study of CUDC-101, a multitargeted inhibitor of HDACs, EGFR, and HER2 in patients with advanced solid tumors.
Shimizu T, LoRusso PM, Papadopoulos KP, Patnaik A, Beeram M, Smith LS, Rasco DW, Mays TA, Chambers G, Ma A, Wang J, Laliberte R, Voi M, Tolcher AW. Shimizu T, et al. Among authors: laliberte r. Clin Cancer Res. 2014 Oct 1;20(19):5032-40. doi: 10.1158/1078-0432.CCR-14-0570. Epub 2014 Aug 8. Clin Cancer Res. 2014. PMID: 25107918 Clinical Trial.
36 results